David A. Siegel Chimerix Inc Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Chimerix Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 27,000 shares of CMRX stock, worth $23,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,000

Previous 22,300 21.08%

Holding current value

$23,220

Previous $21,000 33.33%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.91 - $1.26 $4,277 - $5,922	4,700 Added 21.08%	27,000 $28,000
Q4 2023 Feb 14, 2024	BUY	$0.9 - $1.06 $20,070 - $23,638	22,300 New	22,300 $21,000
Q1 2023 May 15, 2023	SELL	$1.19 - $2.09 $507,297 - $890,966	-426,300 Reduced 90.78%	43,300 $54,000
Q4 2022 Feb 14, 2023	BUY	$1.7 - $2.35 $265,200 - $366,600	156,000 Added 49.74%	469,600 $873,000
Q3 2022 Nov 14, 2022	BUY	$1.82 - $2.76 $570,752 - $865,535	313,600 New	313,600 $605,000

Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $70,216 - $279,816	-52,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $1.53 Million - $2.27 Million	-333,900 Reduced 86.44%	52,400 $240,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $3.01 Million - $4.13 Million	-574,800 Reduced 59.81%	386,300 $2.48 Million
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $65,340 - $96,250	-11,000 Reduced 1.13%	961,100 $5.95 Million
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $1.81 Million - $2.35 Million	240,100 Added 32.8%	972,100 $7.78 Million
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $35,700 - $84,375	-7,500 Reduced 1.01%	732,000 $7.06 Million
Q4 2020 Feb 16, 2021	SELL	$2.43 - $5.42 $154,791 - $345,254	-63,700 Reduced 7.93%	739,500 $3.57 Million
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.72 $8,510 - $13,764	3,700 Added 0.46%	803,200 $2 Million
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $156,142 - $426,162	117,400 Added 17.21%	799,500 $2.48 Million
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $123,063 - $225,777	-96,900 Reduced 12.44%	682,100 $982,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $490,750 - $1.03 Million	377,500 Added 94.02%	779,000 $1.58 Million
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $308,993 - $674,021	160,100 Added 66.32%	401,500 $944,000
Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $27,264 - $57,456	13,300 Added 5.83%	241,400 $1.04 Million
Q1 2019 May 15, 2019	BUY	$1.79 - $3.12 $167,007 - $291,096	93,300 Added 69.21%	228,100 $479,000
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $46,368 - $80,730	20,700 Added 18.14%	134,800 $346,000
Q3 2018 Nov 14, 2018	SELL	$3.58 - $4.9 $100,956 - $138,180	-28,200 Reduced 19.82%	114,100 $444,000
Q2 2018 Aug 14, 2018	SELL	$4.43 - $5.14 $130,241 - $151,116	-29,400 Reduced 17.12%	142,300 $677,000
Q1 2018 May 15, 2018	SELL	$4.65 - $5.9 $9,355 - $11,870	-2,012 Reduced 1.16%	171,700 $893,000
Q4 2017 Feb 14, 2018	BUY	$4.32 - $5.52 $426,003 - $544,338	98,612 Added 131.31%	173,712 $804,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $326,685 - $394,275	75,100	75,100 $394,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

29.6M

Call Options Held

18.9K

Put Options Held

40.9K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $75.4M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account